Evaluation of the Effect of Limosilactobacillus fermentum CECT5716 on Gastrointestinal Infections in Infants: A Systematic Review and Meta-Analysis
Open Access
- 30 June 2021
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 9 (7), 1412
- https://doi.org/10.3390/microorganisms9071412
Abstract
Reducing the incidence of gastrointestinal infections (GIs) that occur at early stages to mitigate hospitalizations and treatments with adverse effects is a promising strategy for providing well-being to infants and their families. This systematic review and meta-analysis explores whether the early administration of Limosilactobacillus fermentum CECT5716 might be effective as a preventive therapy for GIs. We reviewed the literature to identify randomized controlled trials (RCTs) investigating the effectiveness of milk formulas supplemented with L. fermentum CECT5716 administered to infants at early stages to reduce the incidence of GIs. The MEDLINE (via PubMed), Web of Science (WoS), and Cochrane Central Register of Controlled Trials (via CENTRAL) databases were searched up to 15 June 2021. GI data from the included studies were synthesized in a random-effects model. Three RCTs were finally selected including 435 infants. There was a significant reduction in the incidence rate of GIs for those receiving L. fermentum CECT5716 compared with those receiving placebo (IRR: 0.52, 95% CI: 0.36–0.74, p = 0.0004). Heterogeneity between studies was moderate (I2 = 54.5%). Based on the present systematic review and meta-analysis, the administration of L. fermentum CECT5716 at doses from 1 × 109 to 8.4 × 108 cfu/day in milk formulas may prevent GIs in infants up to 12 months old. Longer-term studies including a higher number of infants are needed to determine whether the use of this probiotic during the early stages of life is an efficient way to reduce the incidence of GIs.Keywords
This publication has 59 references indexed in Scilit:
- Bifidobacteriumanimalis subsp. lactis BB-12 in reducing the risk of infections in infancyBritish Journal of Nutrition, 2010
- Treatment of Infectious Mastitis during Lactation: Antibiotics versus Oral Administration of Lactobacilli Isolated from Breast MilkClinical Infectious Diseases, 2010
- Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Prevention and Management of Infections by ProbioticsJournal of Nutrition, 2010
- Isolation of Bifidobacteria from Breast Milk and Assessment of the Bifidobacterial Population by PCR-Denaturing Gradient Gel Electrophoresis and Quantitative Real-Time PCRApplied and Environmental Microbiology, 2009
- Safety Assessment ofLactobacillus fermentumCECT5716, a probiotic strain isolated from human milkJournal of Dairy Research, 2009
- Specific probiotics in reducing the risk of acute infections in infancy – a randomised, double-blind, placebo-controlled studyBritish Journal of Nutrition, 2008
- A comparative study of the preventative effects exerted by two probiotics,Lactobacillus reuteriandLactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitisBritish Journal of Nutrition, 2007
- Probiotic Potential of 3 Lactobacilli Strains Isolated From Breast MilkJournal of Human Lactation, 2005
- Grading quality of evidence and strength of recommendationsBMJ, 2004
- Human milk is a source of lactic acid bacteria for the infant gutThe Journal of Pediatrics, 2003